Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
NeuroFrontiersRecognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
Uncovering TK2d: How to Navigate Diagnostic Challenges
NeuroFrontiersUncovering TK2d: How to Navigate Diagnostic Challenges
Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
NeuroFrontiersA Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
NeuroFrontiersImproving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
Ethan Meltzer, MD
- advertisement
- 3 questions
- advertisement
Guiding Long-Term Care in Friedreich Ataxia
Medical Industry FeatureGuiding Long-Term Care in Friedreich Ataxia
Jennifer Caudle, DO, FACOFP
David Lynch, MD
Laura Bleekrode, MD
A Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Medical Industry FeatureA Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Shiv Bhadola, MD
Taking Action in Friedreich Ataxia From Diagnosis to Treatment
Medical Industry FeatureTaking Action in Friedreich Ataxia From Diagnosis to Treatment
Jennifer Caudle, DO, FACOFP
David Lynch, MD
Laura Bleekrode, MD
Understanding CIDP: Disease Heterogeneity and Diagnostic Challenges
Medical Industry FeatureUnderstanding CIDP: Disease Heterogeneity and Diagnostic Challenges
Jennifer Caudle, DO, FACOFP
Allison Crowell, MD
Cerebral Organoid Model Transforms Glioblastoma Research
Medical Industry FeatureCerebral Organoid Model Transforms Glioblastoma Research
Howard Fine, M.D.
Exploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Medical Industry FeatureExploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Brian P. McDonough, MD, FAAFP
Julie Paik, MD, MHS
- 10/30/2026
- 10/29/2026
- 10/28/2026
- 10/26/2026
- 10/23/2026
- 10/21/2026